Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer

Nienke Zwakman, Rafli van de Laar, Toon Van Gorp, Petra L. M. Zusterzeel, Marc P. M. L. Snijders, Isabel Ferreira, Leon F. A. G. Massuger, Roy F. P. M. Kruitwagen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number7
Number of pages12
JournalJournal of Gynecologic Oncology
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Ovarian Neoplasms
  • CA-125 Antigen
  • Neoplasm
  • Residual
  • Survival
  • Prognosis
  • RESIDUAL DISEASE
  • CYTOREDUCTIVE SURGERY
  • SURGICAL-TREATMENT
  • CA-125
  • DECLINE
  • SIZE

Cite this

Zwakman, N., van de Laar, R., Van Gorp, T., Zusterzeel, P. L. M., Snijders, M. P. M. L., Ferreira, I., Massuger, L. F. A. G., & Kruitwagen, R. F. P. M. (2017). Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer. Journal of Gynecologic Oncology, 28(1), [7]. https://doi.org/10.3802/jgo.2017.28.e7